WG
ABBV icon

Watchman Group’s AbbVie ABBV Stock Holding History

Watchman Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,094
Closed -$224K – 77
2020
Q4 		$224K Buy
+2,094
New +$201K 0.15% 70
2020
Q3 		– Sell
-2,094
Closed -$206K – 76
2020
Q2 		$206K Buy
+2,094
New +$184K 0.17% 75
2020
Q1 		– Sell
-2,494
Closed -$221K – 74
2019
Q4 		$221K Buy
+2,494
New +$207K 0.16% 78

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Watchman Group's ABBV Position: Q1 2021 in Review

Watchman Group sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 2,094 shares — an estimated $224K sold.

Watchman Group first reported a position in ABBV in Q4 2019 and held it in 3 quarters. The position peaked at $224K in Q4 2020. 2,614 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

  • Watchman Group reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
  • Watchman Group sold 2,094 AbbVie shares in Q1 2021, an estimated $224K.
  • Watchman Group first reported a position in AbbVie in Q4 2019 and held it in 3 quarters.
  • Watchman Group's AbbVie position peaked at $224K in Q4 2020.
  • 2,614 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on Watchman Group's 13F filing for Q1 2021, filed 5 May 2021.